USPTO Patent US12582433B2 for Thrombus Removal Systems Granted
Summary
The USPTO has granted patent US12582433B2 for thrombus removal systems and associated methods to Shifamed Holdings, LLC. The patent details systems including an elongated catheter with features for fragmenting and aspirating thrombi from blood vessels.
What changed
The United States Patent and Trademark Office (USPTO) has granted patent US12582433B2 for "Thrombus removal systems and associated methods." The patent, assigned to Shifamed Holdings, LLC, describes a system comprising an elongated catheter with a distal portion for positioning within a patient's blood vessel and a proximal portion external to the patient. Key features include an imaging element, an illumination source, a capture element for engaging thrombi, a fluid delivery mechanism for fragmenting thrombi and providing an optical path, and an aspiration mechanism for removing fragmented thrombi.
This patent grant is a routine event for medical device innovation and does not impose new regulatory obligations on companies. However, it signifies intellectual property protection for Shifamed Holdings, LLC in the area of cardiovascular intervention devices. Companies developing similar technologies should be aware of this granted patent to ensure their products do not infringe upon the protected claims. No immediate compliance actions are required for regulated entities based solely on this patent grant.
Source document (simplified)
Thrombus removal systems and associated methods
Grant US12582433B2 Kind: B2 Mar 24, 2026
Assignee
Shifamed Holdings, LLC
Inventors
Marwan Berrada, Amr Salahieh, Tom Saul, Aadel Al-Jadda
Abstract
The present technology relates to systems and methods for removing a thrombus from a blood vessel of a patient. In some embodiments, the present technology is directed to systems including an elongated catheter having a distal portion configured to be positioned within the blood vessel of the patient, a proximal portion configured to be external to the patient, and a lumen extending therebetween. The system can also include an imaging element at the distal portion, an illumination source at the distal portion, a capture element at the distal portion and configured to engage the thrombus, a fluid delivery mechanism within the lumen and configured to apply fluid to (1) at least partially fragment the thrombus and (2) provide an optical path for the imaging element, and an aspiration mechanism fluidly coupled to the lumen and configured to aspirate the fragmented thrombus.
CPC Classifications
A61B 17/22031 A61B 17/22032 A61B 17/32037 A61B 17/32056 A61B 17/320758 A61B 17/3203 A61B 90/37 A61B 2017/00022 A61B 2017/00026 A61B 2017/003 A61B 2017/00539 A61B 2017/00685 A61B 2017/00778 A61B 2017/00809 A61B 2017/22079 A61B 2017/22082 A61B 2017/22084 A61B 2217/007 A61B 2218/001 A61M 1/71 A61M 1/84 A61M 1/774 A61M 3/0283 A61M 5/16827 A61F 5/442
Filing Date
2021-03-04
Application No.
17905671
Claims
15
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.